AdaptHealth (AHCO)
US Market

AdaptHealth (AHCO) Income Statement


AdaptHealth Income Statement

Last quarter (Q4 2023), AdaptHealth's total revenue was $858.23M, an increase of 9.99% from the same quarter last year. In Q4, AdaptHealth's net income was $-254.50M. See AdaptHealth’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 3.20B-$ 2.97B$ 2.45B$ 1.06B$ 529.64M
Cost of Revenue
$ 2.72B$ 2.72B$ -2.55B$ -2.01B$ 898.60M$ 440.70M
Gross Profit
$ -2.72B$ -2.72B$ 352.54M$ 411.90M$ 157.79M$ 88.94M
Operating Expense
$ 190.09M$ 190.09M$ 162.13M$ 167.50M$ 86.44M$ 59.56M
Operating Income
$ -567.30M$ -598.40M$ 190.41M$ 244.40M$ 71.35M$ 29.38M
Net Non Operating Interest Income Expense
$ -130.30M$ -130.30M$ -109.41M$ -95.19M$ -41.43M$ -39.30M
Other Income Expense
$ -4.92M$ -4.92M$ -16.91M$ -41.76M$ -235.96M$ -11.94M
Pretax Income
$ -723.78M$ -723.78M$ 97.90M$ 190.96M$ -206.04M$ -21.86M
Tax Provision
$ -49.00M$ -49.00M$ 24.77M$ 32.81M$ -11.96M$ 739.00K
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -649.89M$ -678.89M$ 69.32M$ 156.18M$ -161.63M$ -21.34M
Basic EPS
$ -5.07$ -5.06$ 0.47$ 1.12$ -1.23$ -0.66
Diluted EPS
$ -5.35$ -5.31$ 0.33$ 0.67$ -1.23$ -0.66
Basic Average Shares
$ 536.62M$ 134.16M$ 134.18M$ 126.31M$ 52.49M$ 22.56M
Diluted Average Shares
$ 537.67M$ 134.42M$ 138.99M$ 133.03M$ 52.49M$ 22.56M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
----$ 22.34M$ 13.41M
Total Expenses
$ 2.91B$ 2.91B$ -2.39B$ -1.84B$ 985.04M$ 500.27M
Net Income From Continuing And Discontinued Operation
$ -677.93M$ -678.89M$ 69.32M$ 156.18M$ -161.63M$ -21.34M
Normalized Income
$ 34.71M$ 57.66M--$ 63.88M$ -12.40M
Interest Expense
----$ 41.43M$ 39.30M
$ -593.49M$ -593.49M$ 207.32M$ 286.15M$ -164.61M$ 17.44M
$ -167.69M$ -167.69M$ 595.96M$ 578.23M$ -82.17M$ 80.01M
Currency in USD

AdaptHealth Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis